Navigation Links
Samplify Evolves Business Model From IP Developer to Semiconductor Supplier; Now Targets Multi-Billion Dollar Market
Date:10/20/2008

New Class of Silicon Merges High-Performance Data Conversion With Real-Time

Signal Compression

SANTA CLARA, Calif., Oct. 20 /PRNewswire/ -- Samplify Systems, Inc., provider of mixed-signal compression solutions, today announces its move from intellectual property (IP) provider to a fabless semiconductor company with the announcement of its first silicon products. (See today's related press release: Samplify Announces SAM1600 Family) Samplify maximizes the system value of its real-time data compression technology by integrating it into the data converter. This move positions the company to immediately address the multi-billion dollar data conversion and ASSP markets as application commoditized data converters become integrated with ASSPs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080411/AQF028LOGO)

Market research firm Gartner predicts the data converter market will grow at a cumulative annual growth rate of 5.3 percent to over $3.9B by 2011. "The data converter market remains an attractive segment with growth rates exceeding that of the overall semiconductor industry," said Stephan Ohr, semiconductor analyst at Gartner. "However, data converters are increasingly integrated onto larger systems-on-chip (SoC). While this occurs frequently in consumer applications, it is now being applied to industrial, scientific, and medical applications as well."

According to Samplify, the company has penetrated a number of these markets with its Prism(TM) signal compression technology over the past 18 months. Moreover, the company's customers have been pushing Samplify to move compression closer to the analog domain to provide benefits throughout the entire signal chain.

Al Wegener, Samplify founder, chairman, and CTO, notes, "Creating 'intelligent data converters' by integrating the compression engine with data converters is the
'/>"/>

SOURCE Samplify Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Samplify Systems Announces Distribution Agreement With Tokyo Electron Device Limited, Broadening Availability of Signal Compression Technology
2. Samplify Systems Announces Availability of Compression for Computed Tomography; Integrated Slip-Ring Solution to be Jointly Developed with Schleifring und Apparatebau and Tokyo Electron Device Ltd.
3. Samplify Systems Adds Computed Tomography Expert Carl Crawford to Technical Team
4. Samplify Systems Announces Availability of Samplify for Windows Release 2.6, and Samplify for Windows Embedded Edition, Transforming RF Data Recording Applications with X-COM Systems
5. Blue Cross and Blue Shield of Illinois Evolves its Role, Commits to Health and Wellness of Members and Communities
6. Lumension Security to Host Industry Webinar on Protecting Vital Business Data
7. Workplace Privacy & Security as a Business Strategic Advantage
8. deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business
9. Bull Continues Repositioning and Announces the Acquisition of its Medicaid Solutions Business in the United States by Ingenix
10. Academic Medicine Means Business for Ohio: $37.2 Billion Economic Impact for the State
11. SAP Appoints John Papandrea to Lead Healthcare Business Unit

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ember 18, 2009 -- A team of researchers at the Uni...ersity has developed a way to simulate blood flow ...s the basis of a new tool that may help surgeons p..." surgery, which is performed on babies born with ...ers will present their work next week at the 62nd ...
(Date:11/23/2009)...3/PRNewswire/--TheLupusFoundationofAmericaGreaterW...ssprovidingfreeday-to-dayeducation,adviceandresour...hegreaterD.C.area.LFAGW,s35thAnniversaryLuncheonwi...Smith,s,50MassachusettsAve.,N.E.,Washington( map )...$100each.Tablesponsoropportunitiesare$1,500includi...
(Date:11/23/2009)...ofMedicalGenetics(ACMG)EncouragesFamiliestoGatherF...ryDay,Thanksgiving2009 ,, BETHESDA,Md.,Nov.23/...annualNationalFamilyHistoryDay,asdeclaredbytheU.S....(ACMG)encourageseveryonetoknowtheirfamilymedicalhi...ylife-savinginformation,to"starttheconversation"ab...
(Date:11/23/2009)...oTargetIndividualsintheRecommendedPriorityGroups ,.../--TheDepartmentofHealthannouncedtodaytheywillcond...teHealthCentersinDelaware,Lancaster,andLehighcount...cinewillbeadministeredforfreetoindividualsintherec...thevaccine.Thedepartmentasksthatonlyindividualsint...
(Date:11/23/2009)...come children who don,t access health care from th...gnificantly more likely to have unmet health care ...tudy published in the journal Pediatrics . , S...ncing and delivery of quality health care for chil... policy debates about health insurance reform, muc...
Breaking Medicine News(10 mins):Health News:New tool for helping pediatric heart surgery 2Health News:Washington Lupus Chapter Celebrates 35th Anniversary on December 5 2Health News:'Family Health History and Genetics Privacy' is the Newest Addition to the ACMG Genetics & Your Health Video Series 2Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3
...een hampered by high rates of relapse, even after ... Drug Abuse Program of the VU Medical Center in th...he National Institute on Drug Abuse (NIDA) have id... the scientists, led by Dr. Taco J. De Vries of VU...
...rious intestinal disorder if they are given the co...scientists. A research team from Lousiana Uni...nosis, a condition that affects about 1 in 400 new...at stores information on diagnoses, operative repo...
...istant E. coli has emerged as a possible new sourc... inhabitant of the digestive tract that can cause ... while E. coli from bad food is a frequent cause o...own feces. Urinary tract infections are common, es...
...utical company in the United States focusing prima.... Based in Wilmington, Mass., Ascent is a pharmace...y of pediatrics. Medicis Pharmaceutical Corporatio...cialty pharmaceutical company focused on the marke...
...looked at the use of complementary and alternative...t the use of 20 therapies - from acupuncture to yo...A new survey reveals that complementary and altern... was in the transition from the 1960s to the 1970s...
...hod of treating Hepatitis, by administering vitami... the liver, and in severe cases can lead to cirrho...through contact with the blood or body fluids of a...rose and fell depending on whether he was taking t...
Other Medicine News:
(Date:11/23/2009)...SHVILLE,Tenn.,Nov.23/PRNewswire-FirstCall/-- Cumbe...ositivenewtop-lineresultsfromastudyevaluatingthesa...reatingfeverinhospitalizedburnpatients. ,, Stat...tofreducingfeverinburnpatientsoverthefirst24hourso...hsecondorthirddegreeburnscoveringmorethan10percent...
(Date:11/23/2009)...NCOLNSHIRE,Ill.,Nov.23/PRNewswire/--Sarnova,Inc.,t...roductsintheemergencymedicalservices(EMS)andrespir...xecutivestoitsseniormanagementteam.Thenewexecutive...naHill,executivevicepresidentandgeneralcounsel;Ste...obitaille,executivevicepresidentofcorporatedevelop...
(Date:11/23/2009)...LTHAM,Mass.,Nov.23/PRNewswire/--ProteonTherapeutic...sleadproduct,PRT-201,inend-stagerenaldisease(ESRD)...)creation.TheAVGstudyrepresentsProteon,ssecondhuma...ouncingtheinitiationofaPhase1/2studyofPRT-201inESR...AVF)creationearlierthisyear.Proteonalsoannouncesth...
Breaking Medicine Technology:Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 2Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients 3Sarnova Expands Senior Management Team 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 1DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 3Transgenomic Inc Reports Third Quarter 2009 Results 14739 1Transgenomic Inc Reports Third Quarter 2009 Results 14739 2Transgenomic Inc Reports Third Quarter 2009 Results 14739 3Transgenomic Inc Reports Third Quarter 2009 Results 14739 4Transgenomic Inc Reports Third Quarter 2009 Results 14739 5Transgenomic Inc Reports Third Quarter 2009 Results 14739 6Transgenomic Inc Reports Third Quarter 2009 Results 14739 7Orange County Dermatologist Garners Outstanding Results With New Thermage CPT 28R 29 6034 1Orange County Dermatologist Garners Outstanding Results With New Thermage CPT 28R 29 6034 2
... Sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) ...Drugs Advisory Committee voted 10 to 3 in favor of...ug Administration (FDA) to treat patients with non...onstrated in the ATHENA trial, Multaq is the only ...tudy a significant reduction in morbidity and mort...
...or Additional Scientific Data and Withdrawal of Gu...orporated (Nasdaq: VPHM ) today announced its su...(FDA) of comments on FDA,s Office of Generic Drugs...the bioequivalence (BE) of generic copies of Vanco...Vancocin is the only approved product to treat Cl...
Other Medicine Technology:FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone) 2FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone) 3ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance 2ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance 3ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance 4ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance 5ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance 6ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance 7
Ureteroscope
High Power Economy Light Source 250.2 H
STAT NCD Lab Coverage
STAT Growth-BP
Medicine Products: